These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16533694)

  • 1. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis.
    Cheung C; Luo H; Yanagawa B; Leong HS; Samarasekera D; Lai JC; Suarez A; Zhang J; McManus BM
    Cardiovasc Pathol; 2006; 15(2):63-74. PubMed ID: 16533694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction.
    Li J; Schwimmbeck PL; Tschope C; Leschka S; Husmann L; Rutschow S; Reichenbach F; Noutsias M; Kobalz U; Poller W; Spillmann F; Zeichhardt H; Schultheiss HP; Pauschinger M
    Cardiovasc Res; 2002 Nov; 56(2):235-47. PubMed ID: 12393094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myocardial matrix metalloproteinases activities in mice with viral myocarditis and their relationship with cardiac function and myocardial collagen amount].
    Meng XH; Wang Y; Zhuang JX; Chen Y; Jin YP; Han XZ; Wang YL
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):605-8. PubMed ID: 15347449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
    Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
    Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
    Cheung C; Marchant D; Walker EK; Luo Z; Zhang J; Yanagawa B; Rahmani M; Cox J; Overall C; Senior RM; Luo H; McManus BM
    Circulation; 2008 Mar; 117(12):1574-82. PubMed ID: 18332263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in myocardial matrix metalloproteinase activity in mice with viral myocarditis.
    Meng XH; Wang Y; Zhuang JX; Han XZ; Chen Y; Jin YP; Wang YL; Yu YH; Spires JP; Song GJ
    Chin Med J (Engl); 2004 Aug; 117(8):1195-9. PubMed ID: 15361294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system.
    Rutschow S; Leschka S; Westermann D; Puhl K; Weitz A; Ladyszenskij L; Jaeger S; Zeichhardt H; Noutsias M; Schultheiss HP; Tschope C; Pauschinger M
    Eur J Pharmacol; 2010 Mar; 630(1-3):145-51. PubMed ID: 20035743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.
    Malz R; Weithauser A; Tschöpe C; Schultheiss HP; Rauch U
    Cardiovasc Ther; 2014 Jun; 32(3):113-9. PubMed ID: 24533719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
    Pauschinger M; Rutschow S; Chandrasekharan K; Westermann D; Weitz A; Peter Schwimmbeck L; Zeichhardt H; Poller W; Noutsias M; Li J; Schultheiss HP; Tschope C
    Eur J Heart Fail; 2005 Jun; 7(4):444-52. PubMed ID: 15921778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1.
    Crocker SJ; Frausto RF; Whitmire JK; Benning N; Milner R; Whitton JL
    Am J Pathol; 2007 Dec; 171(6):1762-73. PubMed ID: 18055551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis.
    Cheung CT; Deisher TA; Luo H; Yanagawa B; Bonigut S; Samra A; Zhao H; Walker EK; McManus BM
    Lab Invest; 2007 Jul; 87(7):651-61. PubMed ID: 17468777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
    Guenzinger R; Lahm H; Wottke M; Lange R
    ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
    Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
    Rouet-Benzineb P; Buhler JM; Dreyfus P; Delcourt A; Dorent R; Perennec J; Crozatier B; Harf A; Lafuma C
    Eur J Heart Fail; 1999 Dec; 1(4):337-52. PubMed ID: 10937947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
    Shukla V; Kumar Shakya A; Dhole TN; Misra UK
    Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.